Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.

Rovirosa A, Ascaso C, Ordi J, Abellana R, Arenas M, Lejarcegui JA, Pahisa J, Puig-Tintoré LM, Mellado B, Armenteros B, Iglesias X, Biete A.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1320-9.

PMID:
11955745
2.

How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

Rovirosa A, Ascaso C, Ordi J, Arenas M, Valduvieco I, Lejarcegui JA, Pahisa J, Torne A, Biete A.

Clin Transl Oncol. 2009 Oct;11(10):681-7.

PMID:
19828411
3.

[Prognostic factors in uterine sarcomas: a 21-year retrospective study at the Clinic and Provincial Hospital of Barcelona].

Rovirosa A, Ordi J, Ascaso C, Casals J, Lejarcegui A, Iglesias J, Estapé J, Biete A.

Med Clin (Barc). 1998 Jul 11;111(5):172-6. Spanish.

PMID:
9732833
4.

Pathologic prognostic factors in stage I-III uterine carcinosarcoma treated with postoperative radiotherapy.

Rovirosa A, Ascaso C, Arenas M, Ríos I, Del Pino M, Ordi J, Morales J, Gascón M, Pahisa J, Biete A.

Arch Gynecol Obstet. 2014 Aug;290(2):329-34. doi: 10.1007/s00404-014-3202-z. Epub 2014 Mar 15.

PMID:
24633893
5.

The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Cosio S, Tisi G, Lissoni A, Ferrero AM, Cristofani R.

Eur J Gynaecol Oncol. 2002;23(4):295-9.

PMID:
12214727
6.

Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.

Vongtama V, Karlen JR, Piver SM, Tsukada Y, Moore RH.

AJR Am J Roentgenol. 1976 Jan;126(1):139-47.

PMID:
175673
7.

A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.

Wolfson AH, Wolfson DJ, Sittler SY, Breton L, Markoe AM, Schwade JG, Houdek PV, Averette HE, Sevin BU, Penalver M, et al.

Gynecol Oncol. 1994 Jan;52(1):56-62.

PMID:
8307502
8.

Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.

Durnali A, Tokluoğlu S, Özdemir N, Inanç M, Alkiş N, Zengin N, Sönmez ÖU, Küçüköner M; Anatolian Society of Medical Oncology (ASMO).

Asian Pac J Cancer Prev. 2012;13(5):1935-41.

9.

Prognostic factors in uterine sarcoma.

Gadducci A.

Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):783-95. doi: 10.1016/j.bpobgyn.2011.06.002. Epub 2011 Jul 18. Review.

PMID:
21764643
10.

Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.

Bodner-Adler B, Bodner K, Obermair A, Czerwenka K, Petru E, Leodolter S, Mayerhofer K.

Anticancer Res. 2001 Jul-Aug;21(4B):3069-74.

PMID:
11712812
11.

Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.

Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.

Gynecol Oncol. 2001 Oct;83(1):89-94.

PMID:
11585418
12.

Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1277-87. doi: 10.1007/s00432-008-0422-2. Epub 2008 May 28.

PMID:
18506484
13.

Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma.

Djordjevic B, Gien LT, Covens A, Malpica A, Khalifa MA.

Gynecol Oncol. 2009 Oct;115(1):32-6. doi: 10.1016/j.ygyno.2009.06.018. Epub 2009 Jul 28.

PMID:
19640575
14.

Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.

Ghaemmaghami F, Karimi-Zarchi M, Gilani MM, Mousavi A, Behtash N, Ghasemi M.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):421-6.

15.

Retrospective analysis of 105 cases with uterine sarcoma.

Yoney A, Eren B, Eskici S, Salman A, Unsal M.

Bull Cancer. 2008 Mar;95(3):E10-7. doi: 10.1684/bdc.2008.0594.

PMID:
18390406
16.

Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.

Zhang C, Hu W, Jia N, Li Q, Hua K, Tao X, Wang L, Feng W.

Int J Gynecol Cancer. 2015 May;25(4):629-36. doi: 10.1097/IGC.0000000000000350.

PMID:
25633654
17.

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.

Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, Haie-Meder C, Duvillard P.

Cancer. 2000 Mar 15;88(6):1425-31.

PMID:
10717626
18.

Prognostic factors in early-stage leiomyosarcoma of the uterus.

Pelmus M, Penault-Llorca F, Guillou L, Collin F, Bertrand G, Trassard M, Leroux A, Floquet A, Stoeckle E, Thomas L, MacGrogan G.

Int J Gynecol Cancer. 2009 Apr;19(3):385-90. doi: 10.1111/IGC.0b013e3181a1bfbc.

PMID:
19407564
19.

[Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].

Coquard R, Romestaing P, Ardiet JM, Mornex F, Sentenac I, Gérard JP.

Bull Cancer. 1997 Jun;84(6):625-9. Review. French.

PMID:
9295866
20.

Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.

Gao Y, Meng H, Zhang Y, Jiao T, Hui N.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1616-24. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk